The suppressor of cytokine signaling-1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury
about
Epstein-Barr virus interferes with the amplification of IFNalpha secretion by activating suppressor of cytokine signaling 3 in primary human monocytes.p38alpha mitogen-activated protein kinase plays a critical role in cardiomyocyte survival but not in cardiac hypertrophic growth in response to pressure overload.Enhancement of antiviral immunity by small molecule antagonist of suppressor of cytokine signalingViral exploitation of host SOCS protein functionsCoxsackievirus-induced miR-21 disrupts cardiomyocyte interactions via the downregulation of intercalated disk components.AAV vectors for cardiac gene transfer: experimental tools and clinical opportunities.Expression of suppressor of cytokine signaling 1 (SOCS1) impairs viral clearance and exacerbates lung injury during influenza infection.Cardiac-Specific SOCS3 Deletion Prevents In Vivo Myocardial Ischemia Reperfusion Injury through Sustained Activation of Cardioprotective Signaling Molecules.STAT1 modification improves therapeutic effects of interferons on lung cancer cellsAmelioration of coxsackievirus B3-mediated myocarditis by inhibition of tissue inhibitors of matrix metalloproteinase-1.Basal expression levels of IFNAR and Jak-STAT components are determinants of cell-type-specific differences in cardiac antiviral responsesExpression of SOCS1 and SOCS3 genes in human graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.SOCS1 gene transfer accelerates the transition to heart failure through the inhibition of the gp130/JAK/STAT pathway.An emerging adeno-associated viral vector pipeline for cardiac gene therapyRetinal Astrocytes respond to IL-17 differently than Retinal Pigment Epithelial cells.In vivo ablation of type I interferon receptor from cardiomyocytes delays coxsackieviral clearance and accelerates myocardial disease.Role of toll-like receptors in cardiovascular diseases.Viral myocarditis: potential defense mechanisms within the cardiomyocyte against virus infection.SOCS3: A novel therapeutic target for cardioprotection.Small proline-rich protein 1A is a gp130 pathway- and stress-inducible cardioprotective protein.A respiratory syncytial virus persistent-infected cell line system reveals the involvement of SOCS1 in the innate antiviral response.Japanese encephalitis virus upregulates the expression of SOCS3 in mouse brain and Raw264.7 Cells.Recent advances of adapter proteins in the regulation of heart diseases.Promise of adeno-associated virus as a gene therapy vector for cardiovascular diseases.Mapping of a quantitative trait locus controlling susceptibility to Coxsackievirus B3-induced viral hepatitis.FGL2 knockdown improves heart function through regulation of TLR9 signaling in the experimental autoimmune myocarditis rats.Cardiomyocyte-specific transgenic expression of lysyl oxidase-like protein-1 induces cardiac hypertrophy in mice.MicroRNAs regulate the pathogenesis of CVB3-induced viral myocarditis.Conditional transgenic expression of TIR-domain-containing adaptor-inducing interferon-β (TRIF) in the adult mouse heart is protective in acute viral myocarditis.
P2860
Q33650938-D4D372BF-9830-4706-BF5F-3B2F545C4DC7Q34372422-A391A2E6-8380-48B0-93FD-9ED79C861E00Q34543993-B0D53E3B-B1FF-4712-955E-15E6B4489813Q34742146-F7011054-C498-47C2-84A5-33A77ACA3187Q35145377-44E51B58-E798-4E3B-ADC2-0778FCC9E948Q35238264-D4EA5283-E435-47CA-9FDE-AD86DA187AAAQ35513704-05AEF7EB-47D6-4063-AA15-FE47BD19E251Q35641335-91D39CB6-94B2-4073-A03E-CDFF58E0E22BQ36035457-FBC8B8F0-28DE-45EE-8097-4E7D3A740ED3Q36202823-101F9E28-9028-492D-BB6D-10E5B6ADD32EQ36315128-402830D6-D842-485C-805A-852CE0936743Q36761824-A519ECA0-F962-4317-9D93-805C0E6F07A0Q37066155-5D53666A-2988-4DB5-96DB-21327B530002Q37272838-0E97C7F2-31BE-4F44-AC7B-B3B011DB5BC6Q37429326-E20ED2A5-6C18-4F53-8A98-6B12751322E4Q37713958-EB3FC54F-6DBF-4A7E-9A87-6BD681D0B0B6Q37854080-0E114AFA-F93D-43DE-9C7A-488DEF5C1E08Q37876416-5A785FFF-AACB-4881-893E-D07844CC16E0Q38140895-8BBEE7FE-058D-4D8A-A68D-06409534D0DDQ38334938-5378BE8A-6664-4591-B108-7527C8A4D15BQ38858909-60AB29E5-94D6-4E72-BEF6-D6535644D10AQ38941003-E2734259-9F7E-47A5-9384-CA105C4832A7Q38953404-555ACD58-CB04-49B4-B500-1C23A3D8AD18Q39356341-7FDA8B4C-A666-41A6-B860-B65FAA0CE358Q41409130-D70B24CA-7AE4-451F-A8C6-C5D4331A9CE9Q47412576-56B08549-B9B6-4254-BEC5-A46DC6DE628BQ48451097-BF921CFA-29BB-42DE-AFEF-560BEFE3F445Q54281875-74E0792F-AA40-4452-9C17-26E5009B9ACBQ54346098-D44CE137-BD31-4D80-8F54-5FD6F5041C3E
P2860
The suppressor of cytokine signaling-1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
The suppressor of cytokine sig ...... rovirus-induced cardiac injury
@en
The suppressor of cytokine signaling-1
@nl
type
label
The suppressor of cytokine sig ...... rovirus-induced cardiac injury
@en
The suppressor of cytokine signaling-1
@nl
prefLabel
The suppressor of cytokine sig ...... rovirus-induced cardiac injury
@en
The suppressor of cytokine signaling-1
@nl
P2093
P2860
P356
P1476
The suppressor of cytokine sig ...... rovirus-induced cardiac injury
@en
P2093
Akihiko Yoshimura
Dingding Xiong
Hervé Duplain
Hideo Yasukawa
Kenneth R Chien
Kirk U Knowlton
Masahiko Hoshijima
Masakuni Kido
Matthew D Weitzman
Mitsuo Iwatate
P2860
P304
P356
10.1172/JCI16491
P407
P577
2003-02-01T00:00:00Z